awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38826609-392E5A84-B639-483E-A7A5-DD94D320F64F
Q38826609-392E5A84-B639-483E-A7A5-DD94D320F64F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38826609-392E5A84-B639-483E-A7A5-DD94D320F64F
Progress in the mechanism and drug development of castration-resistant prostate cancer.
P2860
Q38826609-392E5A84-B639-483E-A7A5-DD94D320F64F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38826609-392E5A84-B639-483E-A7A5-DD94D320F64F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66984a0c8aaf881ae4e9bea0905f18bdab65dfbb
P2860
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.